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Abstract: 
 
The red blood cell membrane antigens have been associated with several diseases as well 
as susceptibility for specific pathogens. Since Helicobacter pylori (H.pylori)infections 
have been noted to be associated with different red blood cell antigens, several reports 
have been conducted to identify potential host factors that may increase the risk for 
symptomatic infection with this pathogen.  
 
This study aimed to investigate the relationship between symptomatic/successful H. pylori 
infections and ABO/Rh(D), Lewis antigens and secretor status in infected patients. 
 
This is a case-control study. Eighty three patients who experienced symptomatic H. pylori 
infection and eighty five control subjects were analyzed for their gender, body mass index 
(BMI), smoking habits, drug intake, different environmental pollutants, water source and 
quantity of water intake, spicy food intake, ABO blood group, Rh(D) type, Lewis blood 
phenotype, and secretor status. The association of the different variables with H. pylori 
infection was analyzed statistically by Chi-square test.  
 
Analysis of the control subjects for H. pylori specific IgG, revealed that 98% of them were 
positive, although they have never experienced symptoms of infection (asymptomatic). 
Comparison of the patients’ and control groups, showed a statistically significant 
association between H. pylori infection and BMI, drug intake, amount of water intake, 
Lewis phenotype and secretor property. While comparison of the study groups, showed no 
statistically significant association between H. pylori infection and gender, drinking water 
source, spicy and chilly food intake, smoking, exposure to environmental pollution and 
ABO/Rh group.  
 
VIII 
 
In conclusion, there is a high rate of asymptomatic infection with H. pylori among 
Palestinian subjects. H. pylori infection is influenced by host and environmental factors. 
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Chapter One: 
 
 
1. Introduction: 
 
Cells are the basic structural units in all living organisms. Although cells may share many 
common characteristics, they may perform different functions due to the difference in their 
protein-synthesizing ability and their different surrounding environment which may affect 
their gene expression. The cell membrane is concerned with accurately and sensitively 
identifying molecules involved in cell compartmentalization especially controlling the 
interface between the cell and the environment (Gallagher, 2007, Erica et al., 2010). 
 
Red blood cells (RBCs) are the primary cells in the human body and are essential in gas 
transportation process. Scientists grouped humans into four blood groups depending on the 
presence of one (A) or another (B) or both (AB) or none (O) of the antigens on their RBCs. 
The importance of most blood group antigens had been recognized by the immunological 
complications of blood transfusion or pregnancies. However; the molecular structure and 
function of the RBC antigens remained undefined for many decades. Recently due to the 
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advances in molecular genetics and cellular biochemistry resulted in an abundance of new 
information of the structure and function of the RBC surface molecules (Lichtman et al., 
2007;Pourazar, 2007; Lin et al., 2009). 
 
During the twentieth century many researchers including membrane biochemists and 
molecular geneticists showed interest in studying the membrane proteins expressed on the 
surface of the RBCs. These studies have revealed the structure and the function of some of 
these antigens. Additionally, several studies have revealed that some of the RBC antigens 
are used as cellular receptors for different pathogens and support their life cycles and 
pathogenesis. Viruses, bacteria and parasites were found using certain RBC antigens as 
receptors for these pathogens and support their cycle to cause different diseases such as 
examples of pathogens that bind RBCs include  Escherichia coli, Parvovirus B19, 
Helicobacter pylori and Plasmodium falciparum (Pourazar, 2007; Anstee, 2010;  
Yamamoto et al., 2012). 
 
1.1. Red blood cell antigens: 
 
The RBC membrane is about 1% of the total weight of the cell. The membrane has a 
primary role in RBC integrity and together with its skeleton provides the RBCs with their 
flexibility, durability and tensile strength (Lichtman et al., 2007). RBCs have drawn the 
attention of scientists for hundreds of years; a major discovery regarding these cells was 
the elucidation of the RBC surface antigens and their role in blood transfusion (Pasini etal., 
2010). Since the discovery of human blood groups by Landsteiner in 1901, the genetics, 
serology, and biochemistry of the RBCs and blood group antigens were extensively 
studied. Recently the biological functions of some of these antigens were discovered 
(Lewis et al., 2006). 
 
 3 
 
The cell membrane of human cells contains a large assortment of molecules including 
specific receptors responsible for cell-cell signal transduction and the interaction of each 
cell with its surrounding environment (Leninger, 2003).Since 1980 efforts were directed 
towards gene cloning and sequencing of the genes encoding known blood groups and 
identifying proteins anchoring them in the cell membrane (Anstee, 2011). Many of the 
RBC membrane glycoproteins express certain blood group activity as a result of variation 
in their oligosaccharides or amino acid sequences. The clinical relevance of blood group 
antigens in the practice of blood transfusion has led to extensive analysis of the red cell 
surface. Additionally; most genes encoding the different blood group systems have been 
cloned (Burton et al., 2011). 
 
There are about 30 blood antigen systems recognized on the RBCs (Anstee, 2011). A 
group of red cell antigens is determined either by a single genetic locus or closely linked 
loci, such loci are directly or indirectly responsible for forming protein or carbohydrate 
epitopes presented as glycoproteins or glycolipids (e.g. ABO, Lewis, P). Protein-defined 
antigens aredirectly encoded by genesthat follow Mendelian inheritance. These proteins 
are inserted into cell membrane in one of three ways; single pass, multipass, or linked to 
phosphatidylinesitol (GPI-linked). Antigens defined as blood group antigens are generally 
found on RBCs and many other tissues except for the erythroid specific antigens including 
Rhesus (Rh), Landsteiner-Wiener (LW), Kell (K) and MNSs (Lewis et. al., 2006).  
 
Over the years RBC antigens were identified and blood group gene products can be 
schematically divided into five functional categories: i) receptors for exogenous ligands 
like viruses, bacteria and parasites e.g. P glycolipid is the receptor for Parvovirus B19 on 
the surface of the erythroid progenitors, also glycoconjugates carrying Lewis antigen (Leᵃ) 
specificity bind Bordetella pertussis and Staphylococcus aureus toxins; ii) adhesion 
molecules e.g. Knops antigens that are responsible for binding and transporting of 
C3B/C4b coated immunocomplexes; which is also a specific binding of IgG; iii) 
membrane transporters and channels e.g. the product of Diego blood group gene which is 
 4 
 
the exchanger of HCO3-/Cl- and Kidd protein that mediates urea transport or the Colton/ 
aquaprorin-1 protein which mediates water transport; iv) enzymes e.g. Kell glycoprotein 
antigens that play a role in erythropoiesis, also have a part in Zn- metalloproteinases; and 
v) structural proteins e.g. the Diego blood group gene product have a role as a membrane 
skeleton linkage and Gerbich antigen that have a role in RBC shape and integrity 
(Pourazar, 2007; Lin et al., 2009). 
 
1.1.1. ABO blood group system: 
 
The ABO antigens are formed as a result of interaction of three independent loci (ABO, Hh 
and Sese). These genes code for specific glycosyltransferases that in turn add an 
immunodominant sugar to a precursor substance type 1 or type 2. Precursor substance type 
1 refers to a β 1-3 linkage between galactoseand N-acetylglucosamine while it is in type 2, 
the bond between galactose and N-acetylglucosamine is β 1-4 linkage. Structures of ABO 
antigens are illustrated in Figure 1.1. In red cell precursors, the Hh gene (FUT1) is located 
on chromosome 19 and codes for the α-2-L fucosyltransferase which adds fucose to 
precursor substance type 2 generating the H antigen (Figure 2). While in the epithelial the 
Sesegene (FUT2) codes for α-2-L fucosyltransferase that adds fucose to precursor 
substance type 1 converting it to H substance (Figure 1.2) (Harmening, 2005; Lewis et al., 
2006). The expression of A and B antigens (Figure1.3) is determined by the H gene that 
along with type 2 precursor give rise to the basic structure that is needed to form the A or 
B antigens. A and B genes are located onto chromosome 9, the A gene encodes for the 
enzyme α-3-N-acetyl-D-galactosamine which adds the N-acetylgalactoseamine onto the H 
antigen, while the B gene encodes for the enzyme α-3-D-galactosyltransferase which adds 
the D-galactose onto the H antigen. This modification converts the H antigen into A or B 
antigens or even A and B antigens together in a heterozygous individual; when both genes 
are inherited along with the FUT1 gene.  When both alleles are inactivated, this will give 
the O blood group phenotype marked by the expression of H antigen on the cells. 
Mutations inFUT1 gene give rise to the Oh Bombay phenotype (Figure 1.2), in which the 
red cells show the O blood group phenotype and their plasma contains Anti-H antibodies. 
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On the other hand, this may prevent the expression of A or B antigens since there is no H 
precursor, consequently, anti-A and/or anti-B antibodies will be seen in the Bombay 
phenotype plasma (Harmening, 2005; Lewis et al., 2006). 
 
Figure 1.1: Type 1 and 2 H precursor chain. 
 
 
Figure 1.2: The composition of O blood group on the RBC membrane. 
 
Moreover, von Dungern (1911) described the presence of two different A antigens which 
are A1 and A2, later this classification into A1 and A2 was found to account for almost 
99% of all A group individuals. A1 blood group accounts for about 80% of all group A 
while A2 accounts for around 19% of group A. Other weakAsubgroups are rare and 
contribute less than 1% of A group. The A1 and A2 groups differ in the extent to which 
their respective enzymes change the H antigen, which in turn is found in four different 
structures differing in their branching patterns. There are also different subgroups of the B 
antigen; but they are considered to be less important than the A subgroupsthe antigens can 
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be arranged according to their immunogenicity in the following order: 
O>A2>A2B>B>A1>A1B(Harmening, 2005; Lewis et al., 2006). 
 
 
Figure 1.3: Formation of Blood Group A antigen in (a) and formation of Blood Group B in 
(b). 
 
The A, B and H antigens are expressed in the early fetal development but they are not 
being fully developed at birth and they reach their adult levels one year postpartum and 
remain constant for life with slight reduction in the elderly (Harmening, 2005; Lewis et al., 
2006). 
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Defining the nucleotide sequences of the cloned genes and predicting the amino acid 
sequences of the encoded proteins helped in determination of the three-dimensional 
structures which are vital for understanding the nature of the blood group epitopes and 
their cellular functions in cell-cell interaction (Burton et al., 2011). 
 
1.1.2. Rh blood group system: 
 
The Rhesus (Rh) blood system is encoded by three closely linked loci (RHD, RHCE, 
RHAG) present on chromosome 1.  The RHCE gene encodes the Rh C/c and Rh E/e 
antigens and the RHD gene encodes the Rh D antigen. There is no “d” allele and the letter 
“d” is used to indicate the absence of Rh D antigen. Since the most immunogenic antigen 
is the D antigen, it is convenient and practical to classify individuals as D positive or D 
negative (Harmening, 2005; Lewis et al., 2006). 
 
1.1.3. Lewis (Le) blood group system: 
 
Another important blood group system is the Lewis (Le) system which is considered a 
unique system since it is the only one that is not manufactured by the red blood cells but 
manufactured by tissue cells. The Le gene is located on chromosome 19 at the FUT3 locus; 
and it is linked to the Hh and Secretor (Se) genes. This Le gene encodes for α-4-L-
fucosyltransferase, which transfers L-fucose to a special precursor chain oligosaccharide 
on glycoprotein or glycolipid structures. Leᵃ phenotype is produced when Le gene is 
segregated from Se gene. The Leᵇ phenotype is produced when both Le and Se genes are 
present.  Le gene is required for the production of either Leᵃ or Leᵇ phenotypes. The 
inheritance of the Le gene acts in competition with ABO genes adding L-fucose to the 
special sugar precursor that is manufactured by tissue cells. The final structure which is a 
soluble antigen is secreted and adsorbed or acquired by RBCs, lymphocytes, and platelet 
membrane.  The antigen is also found on cells of pancreas, stomach, intestine, skeletal 
muscles, renal cortex, and adrenal glands. The frequency of Lewis phenotypes is: (72%) 
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forLe(a-,b+), (22%) for Le(a+,b-) and (6%) for Le(a-,b-). Additionally, the 
phenotypeLe(a+,b+) is rarely produced as a result of a mutation in the FUT2 gene which is 
SewA385T. The phenotype associated with the SewA385T mutation is partially secretor 
(Henry et al., 1996; Harmening, 2005; Lewis et al., 2006).   
 
1.1.4. ABH soluble substances: 
 
In 1930, the classification of individuals into secretors and non-secretors has been 
established according to the ability of an individual to secret soluble ABH blood group 
antigens. The ABH antigens and their precursor on blood cells and platelets are present on 
other tissue cells and are differentially found in secretor body fluids such as saliva, urine, 
tears, semen, breast milk and gastric juice. The FUT2 or Secretor (Se) gene on 
chromosome 19 is used to classify individuals as secretors when they have the genotype 
(SeSe or Sese) or non-secretors when they have the genotype (sese). The FUT2 gene codes 
for a α-1, 2-L-fucosyltransferase which adds L-fucose to a precursor substance to generate 
the H substance. The H substance is then modified by the A or B enzymes generating the 
A and B soluble antigens, respectively. The secretor enzyme is active in mucus membranes 
and glands and is responsible for the secretion of blood group antigens in the different 
body fluids. The majority of the population (80%) expresses the secretor phenotype, while 
the remaining 20% expresses the non-secretor phenotype (Harmening, 2005; Lewis et al., 
2006; Jaff, 2010). 
 
1.2. Frequency of blood group antigens: 
 
Determining the frequency of each blood group antigen is very important for clinical 
aspects so there are many studies to determine them all over the world. In Palestine, the 
frequency of ABO blood groups in West Bank region were found to be as follows: O 
41.2%, A 39.5%, B 11.4% and AB 7.9% (Al-Kawasmi, 2011). Similar results were 
reported in the West bank region by Shtayeh et al., (1988), and in Gaza Strip by Skaiket. al. 
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(2007). These results are closely similar to frequency of ABO blood groups in different 
countries worldwide with slight variation between the A and O blood groups (Bashwari et 
al., 2001; Hassan, 2010; Eweidah et al., 2011). However, the frequency of Rh(D) positive 
is about  80% and the frequency of Rh(D) negative is about 20% worldwide (Magen David 
Adom, 2013; Bashwari et al., 2001; Skaik et al., 2007;Eweidah et al., 2011). 
 
1.3. Blood group antigens and disease association: 
 
Many studies have found strong correlations between individual’s susceptibility to some 
diseases and secretor status. There are clear relationship between infectious diseases and 
inherited polymorphism in genes encoding and regulating the expression of ABH and 
Lewis antigens in the body secretions. The most important pathogens that may have this 
correlation are Helicobacter pylori (H. pylori), norvovirus, cholera infections, and malaria 
(Anstee, 2010; Yamamoto et al., 2012; Valliani et al., 2013). H. pylori is considered a 
major human pathogen, it is a gram negative spiral bacterium. It’s estimated that H. pylori 
has infected one half of the world’s population. H. pylori infections are most likely 
affected by host and environmental factors. Diseases described by H. pylori and related 
species include peptic ulcer, chronic gastritis, adenolymphoma, lymphoma, stomach 
malignancies, gastric, hepatic and colon cancers. Some of H. pylori strains are associated 
with gastroesophageal reflux disease (Appelmelk, 2000; Jonge et al., 2004; Barghouthi, 
2009). 
 
The clinical outcome of H. pylori infection is determined by the complex interaction 
between the bacterium and the host (Torres et al., 2008). Bacterial adherence to gastric 
epithelial cells may protect the bacterium against peristalsis and mucosal shedding and 
warrants access to nutrients that are released from damaged epithelia. Putative outer 
membrane proteins (OMPs; AlpA, AlpB, BabA, SabA, Oip A and HopZ) are associated 
with adhesion of the bacterium to host cells (Jonge et al., 2004; Torres et al., 2008). H. 
pylori developed its ability to adhere to different host receptors; some of its OMPs bind to 
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fucosylated blood group antigens e.g. BabA, while others may bind to sialytated Le blood 
group antigens (located on epithelial cells). There is evidence that the dynamics of mucosal 
glycosylation is a response to this bacterial infection that may cause a modulation in the 
expression of adhesion molecules as a response to the changes in the host mucosa 
(Mcguckin et al., 2007; Sheu et al., 2007; Linden et al., 2008; Torres et al., 2008; 
Yamamoto et al., 2012; Valliani et al., 2013). In the early stages of colonization, OMPs of 
the bacterium bind to certain cellular antigens in the mucosa, this is followed by changing 
the environment and antigen expression which may increase binding (Mcguckin et al., 
2007; Torres et al., 2008). 
 
The mechanism of persistent infection of H. pylori is not clearly understood. Molecular 
mimicry between bacteria and human gastric environment, adaptation to host, the 
induction of autoreactive antibodies, or gastric damage may all be involved in colonization. 
One of the most important antigens that are expressed by human cells and play a major 
role in the host-parasite interaction is the Le blood group antigens that are normally present 
on the human gastric mucosa cells and on the lipopolysaccharide chains of H. pylori (Sheu 
et al., 2007). 
 
1.4. Literature Review: 
 
Hirszfeld and Hirezfeld in 1919 were the first to point out the differences in the 
distribution of blood groups among different populations. The ABH antigens were shown 
to be widely expressed by all body cells including RBCs as described (Anstee, 2010).  
 
One of the most obvious and significant associations between blood group type and 
diseases are A, B and AB groups which have a higher risk to arterial and venous 
thromboembolisms while the O-group population has a lower risk. These studies are 
supported by the finding that non-group O patients have higher levels of von Willebrand 
factor and coagulation factor VIII. The O blood group was noticed to have reduced 
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Plasmodium falciparum infections compared to non-O blood groups; on the other hand 
Vibreocholerae and Escherichia coli infections were found to be more severe in O blood 
group patients than non-O blood groups (Anstee, 2010). Although some diseases are more 
induced by secretors such as influenze viruses, rhinoviruses, respiratory syncytial virus and 
echoviruses (Raza et al., 1991), there are other pathogens that are more sensitive in non-
secretor population such as Haemophilusinfluenzae, Neisseria meningitidis, Streptococcus 
pneumoniae and urinary tract infections caused by Escherichia coli (Sheinfled et al., 
1989).  
 
One of the first observed associations between blood group phenotypes with disease was 
blood group O and peptic ulceration. H. pylori which is considered to be the causative 
agent for peptic ulceration and gastric cancer was strongly associated with blood group O, 
Lewis antigens especially Le(a-b+) phenotype and secretor property, especially that there 
are evidence demonstrated that Leᵇ antigen acts as a receptor for H. pylori, this antigen is 
most frequently found on O blood group compared to other groups (Anstee, 2010; Jaff et 
al., 2011; Yamamoto et al., 2012; Valliani et al., 2013). Another study showed a 
correlation between this infection and blood group O with a nonsecretor phenotype 
property (Jaff et al., 2011). 
 
Worldwide,H. pylori cause the most common chronic infections; despite the advances in 
understanding its biology, the factors that determine the outcome of infection are still 
poorly understood. Host factors might seem to be very important in the outcome of these 
infections since only a proportion of infected subjects develop ulcers, while the bacterial 
factors have a role in influencing the inflammatory response and the development of a 
more severe infection (Wu et al., 2003; Jafarzadeh et al., 2007). 
 
Several studies found that the lipopolysaccharides of certain strains of H. pylori outer 
membrane contains molecules that share molecular similarity with different antigens 
expressed on the human gastric mucosa. For example, H. pylori synthesize polysaccharides 
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that have close similarity to the Le blood group antigens especially Le
x
 and Leʸ 
(Magdalena et al., 1998; Hynes et al., 2000; Monteiro et al., 2000). 
 
When H. pylori colonize the human host it binds to the gastric mucin, rather than directly 
to muocosal epithelium protecting itself from luminal acidity and shedding. Le antigens 
expressed by H. pylori may mediate the adhesion and colonization of bacteria by 
suppressing the immune response against the bacterium so it may play a role in certain 
autoimmune aspects of pathogenesis. These similarities could potentially allow the 
bacterium to escape immunity and mediate the bacterial attachment by depending on the 
expression of Le antigens on the human gastric epithelium. Due to structural similarity of 
bacterial Le antigens and that of the host Le antigens, production of cross reacting immune 
response with human gastric mucosa and with different gastric proton pumps is manifested 
as an autoimmune disease (Magdalena et al., 1998; Hynes et al., 2000; Monteiro et al., 
2000; Harvey et al., 2010) that may relate to carcinogenesis.  
 
Alternatively, H. pylori may induce a humoral response in infected subjects, however this 
humoral response does not protect against the pathogen (Magdalena et al., 1998). 
 
For more than four decades the association between H. pylori and blood antigens is known 
but received little attention (Harvey et al., 2010). Lewis associated antigens that may have 
a primary role in H. pylori adherence are carbohydrates related biochemically to the ABO 
blood groups and carried on both glycoproteins and glycolipids and comprise type 1 (Le
a
 , 
Leᵇ) and type 2 (Lex, Leʸ) carbohydrates. The determinants of Le antigens are 
oligosaccharides synthesized by the sequential addition of sugar units to oligosaccharide 
chains by fucosyltransferases that are synthesized by Hh, Se, and Le genes. Le
a
 and Leᵇ 
antigens synthesized on type 1 precursor’s oligosaccharides chains that are expressed on 
the digestive and respiratory tracts and in secretions. Le
x
 and Leʸ antigens synthesized on 
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type 2 are expressed on erythrocytes and vascular endothelial cells (Lee et al., 2006; 
Harvey et al., 2010; Yamamoto et al., 2012; Valliani et al., 2013). 
 
This antigen expression in the digestive organs is biologically more important than the 
expression on the erythrocytes, due to its role in mediating bacterial adherence and 
attachment that is considered to be essential steps in the initiation, establishment and 
maintenance of the infection and monoclonal antibodies to Leᵇ inhibit this adhesion (Lee et 
al., 2006; Valliani et al., 2013). 
 
Martiuset al. (2006) observed a significant increase of blood group phenotypes O, A2 and 
Le(a-,b+) in Brazilian patients with H. pylori infections. Increased H. pylori infection was 
more observed among secretors compared to non-secretors.  In contrast, Rio Preto et al. 
(2002) found that there is no correlation between H. pylori infection and O blood group, 
neither Lewis antigens nor secretor status among Brazilian patients.  
 
Kanbay et al. (2005) found a strong correlation between A and O blood groups, and the 
Le(a-,b+) phenotype and H. pyloriinfection. The presence of Le(a-,b+) in A, B and AB 
blood groups was associated with failure of H. pylori to bind to the gastric mucosa, while 
the association of A blood group with the gastric ulcer and carcinoma was not explained. 
Furthermore patients with AB blood group were less positive for H. pylori infections and 
this was the first indication of a negative relationship between H. pylori infections and AB 
blood group. The authors also found a correlation between age and the seroprevalance 
infections of H. pylori. Additionally, H. pylori infection among females was higher 
compared to males. In addition smokers were found to be more susceptible than non- 
smokers (Kanbay et al., 2005). In another study by Jaff et al. (2011) female gender was 
also found to have more risk factor for this infection rather than males and B blood group 
have more protective effect than other groups, and age of infection is mainly during 
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childhood and early adolescence increasing to reach its peak at 31 years old (Jaff et al., 
2011). 
 
In Turkey, Bayan et al. (2009) reported a relationship between blood group O, Le(a-,b+) 
and adherence of H. pylori by using its adhesion protein BabA (Bayan et al., 2009). A 
study by Linden et al. (2008) was performed on Rhesus monkeys originating from south 
Asia found that monkeys were susceptible to H. pyloriinfection when their bloodgroup was 
B along with secretor gene status (Linden et al., 2008). These results were also confirmed 
by several other studies using different a methodologies (Loffeld et al., 1991; Clyne et al., 
1997; Keller et al., 2002; Turkolmez et al., 2007). 
 
On the other hand,some studies did not observe any relationship between blood group 
phenotype and H. pylori infections (Loffeledet al., 1991; Clyneet al., 1997; Keller et al., 
2002; Seydaet al., 2007) and concluded that H. pylori infection neither depends on the 
expression of different blood groups nor on the expression of Le antigens on the RBCs or 
on epithelial cells of the gastric mucosa. 
 
Several studies have investigated the association between ABO/ Rh blood groups, Lewis 
system and secretor status and H. pylori infection. The finding of these studies showed 
contradictory results in different countries and races. However, such information 
concerning the Palestinian patients are not yet available. 
 
1.5. Objectives of the Study: 
 
H. pylori infection is common among most populations. Several studies have been 
conducted to investigate the correlation between H. pylori infection and blood groups. 
However, these studies have reported controversial results and did not yield a conclusive 
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result about this issue, which may be attributed in part to the ethnicity of the studied 
population, the different frequencies of blood groups and other environmental factors. In 
Palestine, there is a lack of local studies on this issue although high prevalence of H. pylori 
infection was reported. The investigation of the relationship between H. pylori infection 
and certain blood groups may help to shed some light on the susceptibility of Palestinian 
population to this infectious agent and the severity of infection and consequently improve 
prevention and management of infection. 
 
Therefore, the main objective of this study is: 
 
To investigate the relationship between symptomatic/successful H. pylori infections on one 
hand and ABO/Rh(D), Lewis antigens, A1 and A2 subgroups, and secretor status in the 
Palestinian patients compared to other studies on the other hand. 
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Chapter Two: 
 
 
2. Materials and Methods: 
 
2.1.Materials: 
 
All materials used in this study are listed in Table 2.1. 
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Table 2.1: Materials used in this study. 
Item 
Catalog 
number 
Manufacturer/ Country 
Plain Tubes   
EDTA Tubes   
0.9% Saline   
Baxter- BAC II(Blood Bank) 
Centrifuge 
  
Plastic Test Tubes 75X12 mm   
Volumetric Pipettes  Thermo Finepipette 
Human Anti-A 600010 Lorne Laboratories Limited 
Human Anti-B 610010 Lorne Laboratories Limited 
Human Anti-D 740010 Lorne Laboratories Limited 
Human Anti-A1 116005 Lorne Laboratories Limited 
Human Anti-H 115002 Lorne Laboratories Limited 
Human Anti-Leᵃ 630002 Lorne Laboratories Limited 
Human Anti-Leᵇ 631002 Lorne Laboratories Limited 
Swinging Centrifuge (Kubota 
5100) 
  
Clean Cups   
Washed RBCs A-cells   
Washed RBCs B-cells   
Washed RBCs O-cells   
Nova Tec Anti- IgG H. pylori 
ELISA Kit 
HELG0220 
ImmunodiagnosticaGmbh 
Germany 
BioTech ELISA Reader   
 
2.2.Methods: 
 
2.2.1. Questionnaire: 
 
A questionnaire was prepared for this study and aimed to collect information from the 
study samples (patients and controls) concerning socioeconomic information, 
anthropometric indices, and medical history. The questionnaire form is shown in Appendix 
A. The questionnaire form also contained a consent form in Appendix B; each subject 
participating in the study was asked to read and sign this form.  
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2.2.2. Study Samples: 
 
Subjects were grouped into two groups, the patients’ group and control group.  
 
Patients’ group: The patients’ group contained individuals who were diagnosed to have 
Helicobacter pylori infection due to symptomatic disease, and were receiving medication 
to treat their disease. In this group the diagnosis of H. pylori infection was confirmed by 
histopathology examination of gastric biopsy. 
 
Patients presenting at the Gastroscopy clinics at Hebron and Ramallah Hospital/ Palestine 
Medical Complex in Ramallah, either for assessment or confirmation of H. pylori infection 
were asked for participation in the study and have given a written consent form. Gastric 
biopsies were sent to the Pathology department at BietJala Hospital in BietJala for 
Histopathology examination. Samples that tested positive for H. pylori infection by 
Histopathology examination were retained for further analysis (patient’s group) while 
those which tested negative were excluded from the study. All subjects were non-relatives 
in order to eliminate other genetic correlations. The patients’ group contained 83 subjects 
from different Palestinian cities. Samples of blood and saliva were collected between 
January 2012 and November 2012. 
 
Control group: This group contained individuals who never contracted symptoms of H. 
pylori infection, never had stomachache for a long period of time, or never been tested for 
H. pylori infection. 
 
These individuals were from different institutes and they were not related to each other or 
to the patients in order to eliminate any other genetic correlations. The control group 
contained 85 subjects from different Palestinian cities.Samples of blood and saliva were 
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collected during the same period as for the patients’ group. All subjects who accepted to 
participate in this study were asked to give a written consent. 
 
2.2.3. Blood and Saliva Samples: 
 
All subjects (patients’ and controls) who accepted to participate in this study were asked to 
fill the study questionnaire, sign the consent form and donate a blood and saliva samples.  
Blood was collected into one EDTA and one plain tube, and saliva into clean cups. To 
enhance secretion of saliva, subjects were given a sugarless gum (Orbit) and asked to chew 
it for 3 minutes before collecting the saliva sample. Saliva was collected into wide mouth 
clean cups, kept at 4ºC  and was processed within 24 hours. EDTA whole blood was kept 
at 4ºC and used for blood grouping within 24 hours. Blood samples collected in plain 
tubes, were allowed to stand at room temperature for 1 hour and then centrifuged at 5000 
rpm for 5 minutes in a fixed-angle centrifuge; serum was harvested and stored at -25ºC 
until use.   
 
2.2.4. Blood Grouping: 
 
2.2.4.1.Procedure: 
 
Typing for the ABO, Rh(D) and Lewis antigens was performed using the tube method. 
Four drops of EDTA whole blood were washed 3X in sterile saline (0.09% NaCl), then 
washed RBCs were resuspended in sterile saline to give 2-5% RBCs suspension. Five test 
tubes were labeled with A, B, D, Le
a
 and Le
b
 and one drop of blood grouping sera (anti-A, 
anti-B, anti-D, anti-Leᵃ and anti-Leᵇ) was placed in the appropriately labeled tubes then an 
equal volume of 2-5% RBCs suspension was added to each tube. Contents were mixed 
gently and for Lewis blood antigens typing, the respective test tubes (anti-Leᵃ and anti-Leᵇ) 
were incubated at room temperature for 15 minutes. All tubes were centrifuged using the 
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immediate spin program (1000 rpm for 20 seconds, Baxter, BAC II blood bank centrifuge). 
Every individual that was positive for anti-A was retyped with Anti-A1 to differentiate A1 
antigens from A2 antigens. 
 
2.2.4.2.Interpretation of results: 
 
1. Positive: Agglutination of RBCs within the accepted limitations of the test 
procedure indicated the presence of the particular antigen on the tested RBCs. 
 
2. Negative: No agglutination of test RBCs constitutes a negative result and within 
the accepted limitations of the test procedure, this will indicates the absence of 
the particular antigen on the tested RBCs. 
 
2.2.4.3.Stability of the Reactions: 
 
1. RBCs were tested for antigens within 24 hours in order to have good results, as 
long storage may cause poor detection of certain antigens especially Leᵃ and 
Leᵇ. 
 
2. Testing of blood group antigens was done using the recommendations of the 
manufacturer of the typing sera. 
 
3. Tests were read immediately after centrifugation because delays result in 
dissociation of antigen- antibody complexes leading to false negative or weak 
positive reactions. 
 
4. Every negative macroscopically result of the Rh testing was confirmed 
microscopically, because certain antigens show very weak reaction that 
couldn’t be identified macroscopically. 
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2.2.5. Determination of the Secretor Property: 
 
2.2.5.1.Procedure: 
 
The secretor property was determined using the Hem-agglutination method. Human 
polyclonal ani-A, anti-B and anti-H sera were diluted by titration against appropriate cells 
at immediate spin using saline. The appropriate dilution that gave +2 agglutination was 
selected for further use in this procedure. For anti-A and anti-B the appropriate dilution 
was 1:40, while for anti-H it was 1:2. Two to three mL Saliva sample was placed into a 
clean test tube. Saliva tubes were centrifuged at 900-1000 rpm for 8-10 minutes.The 
supernatantwas transferred into a clean glass test tube; cap was closed properly, and then 
placed into a boiling water bath for 10 minutes. Boiling is used to inactivate enzymes that 
might destroy blood group substances.Then all tubes were re-centrifuged at 900-1000 rpm 
for 8-10 minutes and the supernatant was collected into a clean tube.Then the supernatant 
was then diluted 1:5 with saline. Undiluted saliva contains nonspecific glycoproteins that 
can inhibit antisera and leads to incorrect results.One drop of diluted saliva was mixed with 
one drop of the diluted antisera (anti-A, anti-B and anti-H) in the appropriately labeled 
tube. Tubes were mixed well and incubated at room temperature for 8-10 minutes.To the 
saliva-antisera mixture, one drop of the appropriate indicator cells (2-5% washed cell 
suspension of A, B or O cells) was added to the properly labeled tube.All tubes were 
mixed well and incubated at room temperature for 30- 60 minutes, after this tubes were 
centrifuged using immediate spin program (1000 rpm for 20 seconds) using the blood bank 
centrifuge, and all agglutination results were examined macroscopically. 
 
2.2.5.2.Interpretation: 
 
1- Non-Secretor: Agglutination of RBCs by antiserum- saliva mixture in all three 
tubes (Table 2.2.). 
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2- Secretor: No agglutination of RBCs by antiserum and saliva mixture. The 
antiserum has been neutralized by the soluble blood group substances or antigens in 
the saliva. Therefore, no free antibody is available to react with the antigens on the 
reagent RBCs used in the testing. This negative reaction is a positive test for the 
presence of ABH-soluble antigens and indicates that the individual is a secretor 
(Table 2.2.). 
 
Table 2.2: ABH Substances in Saliva. 
ABH substances in saliva 
ABO Group A B H 
Secretors 
A Much None Some 
B None Much Some 
O None None Much 
AB Much Much Some 
Non-Secretors 
A, B, O and AB None None None 
 
 
2.2.6. H. pyloriIgG ELISA: 
 
The IgG antibody against H. pylori was determined in the serum of control group using the 
Nova Tec kit (ImmunodiagnosticaGmbh), a commercially available ELISA (Enzyme 
Linked Immuno-Sorbent Assay) kit, was used for the determination of the IgG class 
antibodies against H. pylori in serum samples. This kit can be used for qualitative and 
quantitative determination of the IgG class against this bacterium. In the present study it 
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was used for quantitative determination of the antibody.The anti-H.pyloriIgG was 
determined in the serum of control subjects only to test for their previous asymptomatic 
exposure to the bacterium.  
 
2.2.6.1.Principle of the assay: 
 
The quantitative determination of the H. pyloriIgG antibody was performed according to 
the manufacturer’s instructions. In the Nova Tec ELISA kit the H. pylori antigens are 
coated on the microtiter wells and are used to bind the anti- H. pyloriIgG antibodies in the 
serum. After washing the wells to remove all unbound sample material, horseradish 
peroxidase (HRP) labeled anti-human IgG conjugate is added. This conjugate binds to the 
captured Helicobacter specific antibodies. The immune complex formed by the bound 
conjugate is visualized by adding Tetramethylbenzidine (TMB) substrate which gives a 
blue reaction product. 
 
The intensity of this product is proportional to the amount of Helicobacter specific IgG 
antibodies in the specimen. Sulphuric acid is added to stop the reaction. This produces a 
yellow endpoint color. Absorbance at 450 nm is read using ELISA microwell plate reader. 
 
All reagents and materials required for the ELISA wereprovided with the kit and were 
prepared per the manufacturer recommendations. 
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2.2.6.2.Assay Procedure: 
 
2.2.6.2.1. ELISA testing: 
 
Serum samples of control group were thawed at room temperature, diluted 1+100 with IgG 
diluent and mixed using a vortex mixer.Substrate Blank well was kept as a reference for 
the assay.One-hundred ul of each standard (A, B, C and D) and diluted samples were 
dispensed into the respective wells. Wells were covered with foil and incubated at 37°C for 
one hour. After incubation the foil was removed and the fluid in the wells were aspirated 
and discarded.Each well was washed three times with 300 ul of washing solution and 
soaking of wells each time for more than 5 seconds. Then one-hundred ul of H. pylori anti 
IgG conjugate was dispensed into all wells except the blank well. Wells were covered with 
foil and incubated at room temperature for 30 minutes. Wells were washed three times as 
described in the previous step. One-hundred ul of TMB substrate solution was dispensed 
into all wells and microtiter plate was incubated for 15 minutes at room temperature in the 
dark. To stop the reaction, 100ul of the stop solution (sulphuric acid) was added onto the 
wells in the same order and rate of the TMB substrate solution. The absorbance of the 
specimens was measured at 450/620 nm within 30 minutes after addition of the stop 
solution. The absorbance was read using the BioTech ELISA reader.  
 
2.2.6.2.2. Assay Validation: 
 
In order to consider the assay valid, the following criteria were applied per the 
manufacturer’s instructions: 
- Substrate Blank absorbance < 0.100. 
- Standard A concentration= 0 NTU/mL, has absorbance < 0.200. 
- Standard B concentration= 15 NTU/mL, has absorbance > 0.200. 
- Standard C concentration= 75 NTU/mL, has absorbance > 0.500. 
- Standard D concentration= 150 NTU/mL, has absorbance > 1.100. 
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Standard A< Standard B< Standard C< Standard D. 
 
2.2.6.2.3. Calculation of IgG titer: 
 
To obtain a quantitative result measured by NTU/mL, the mean of standards’ absorbance 
(A, B, C and D) was blotted on a Linear/ Linear graph, the standard calibration curve 
(Figure 2.1). 
 
Figure 2.1: H. pyloriIgG ELISA Calibration Curve. 
 
2.2.6.2.4. Interpretation of Results: 
 
Values provided by the kit as guidelines: 
Reactive: >20 NTU/mL. 
Gray zone (equivocal): 15- 20 NTU/mL. 
Non-reactive: < 15 NTU/mL. 
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2.2.6.2.5. Specific Performance Characteristics: 
 
2.2.6.2.5.1.Precision: 
 
a- Interassya: CV%= 5.1%. 
b- Intraassay: CV%= 6.5%. 
 
2.2.6.2.5.2.Diagnostic Specificity: 
 
The diagnostic specificity is defined as the probability of the assay to score negative in the 
absence of the specific analyte. For this kit it is 92.0% (95% confidence interval 0.84- 
0.99). 
 
2.2.6.2.5.3.Diagnostic Sensitivity: 
 
The diagnostic sensitivity is defined as the probability of the assay to score positive in the 
presence of the specific analyte. For this kit it is 94.4% (95% confidence interval 0.87- 1). 
 
2.2.6.2.5.4.Analytical Sensitivity: 
 
The analytical sensitivity is defined as the apparent concentration of the analyte that can be 
distinguished from the Zero calibration. For this kit it is 3 NTU/mL. 
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2.2.6.2.5.5.Interferences: 
 
Interferences with hemolytic, lipemic or icteric serum are not observed up to a 
concentration of 10 mg/mL hemoglobin, 5 mg/mL Triglycerides and 0.2 mg/mL bilirubin. 
These interferences were considered while running the assay for the control group. 
 
2.2.7. Statistical analysis: 
 
All data are shown as mean ± SD. Statistical analysis was performed using the SPSS 
software (version IBM SPSS statistics 20.Ink).  
 
All variables were tested by Pearson’s Chi-square (χ²) test which calculates the goodness 
of fit and independency between variables, and were evaluated using the P-value.P-value 
less than 0.05 was considered statistically significant. 
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Chapter Three: 
 
 
3. Results: 
 
3.1.Study samples: 
 
Several host and environmental factors influence the outcome of Helicobacter 
pyloriinfection. Some of the complex factors of interaction between the bacterium and the 
host (Torres et al., 2008) were targeted in this study to show their correlation and 
interaction with the bacterial colonization and disease complications. These factors were 
tested statistically for their significant association with H. pylori infection. Patients and 
control groups were analyzed for their age, gender, body mass index (BMI), smoking 
habits, chronic drug intake, different environmental pollutants, water source and quantity 
of water intake, spicy food intake, ABO blood group, Rh system type, Lewis blood 
phenotype, and secretor status. Two groups of patients (symptomatic) and control 
(asymptomatic), were compared for different variables, statistical correlation of these 
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variables were tested. Data analyses were performed using Pearson’s Chi-Square test to 
study the association between the study variables and H. pylori infection.  
 
Subjects (n=83) of the patients’ group were diagnosed to have the infection mainly by 
histopathological examination of stomach biopsies(60 samples, 72.3%), testing for serum 
H. pylori specific IgA (20 samples, 24.1%) or bytesting for H. pylori specific antigens in 
stool (3 samples, 3.6%). Patients are thoseexperienced symptomatic H. pylori infection and 
have received or were receiving the triple antibiotic therapy that contains tetracycline, 
metronidazole and bismuth subsalicylate as a treatment at the time of sample collection 
(Graham et al., 1992). On the other hand, controls were selected from different institutes 
and had volunteered to participate in the study; they were healthy and did not experience 
symptoms of H. pylori infection such as abdominal pain or continuous burning abdominal 
pain(Hawkey et al., 2005). This group was tested for asymptomatic exposure to H. pylori 
by serological testing for anti-H. pyloriIgG antibodies in their sera.None of the control 
group subjects had been previously tested positive for H. pylori nor did they receive any 
treatment for this purpose. 
 
Both study groups were collected from different Palestinian geographic areas (Jenin, 
Nablus, Qalqelia, Ramallah, Jerusalem, Bethlehem and Hebron. These subjects were 
categorized into three geographic groups; north, central and south regions of West Bank, 
Palestine, as shown in Table 3.1. Patients and control groups were non-kin (not related) in 
order to exclude genetic variables. 
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Table 3.1: Distribution of patient and control subjects by place of residence. 
Residence place 
Patients’ group Control group 
No. % No. % 
North region (Jenin, Nablus, 
Qalqelia) 
13 15.7 6 7.1 
Central region (Ramallah, 
Jerusalem) 
38 45.8 46 54.1 
South region (Bethlehem, 
Hebron) 
32 38.6 33 38.8 
Total 83 100 85 100 
 
3.1. Age: 
 
The average age of the patients’ group was 37.6 years (SD= 14.4), while that of the control 
group was 27.3 years (SD= 10.5). The main deviation in the age mean was due to the low 
response rate in older age subjects to participate in this study. Although, this difference 
was statistically significant (P=0.000), it had no association with the level of exposure to 
H. pylori (H. pylori infection). This difference in age between the whole study groups has 
no effect on all variable investigated in this study except for the amount of water intake 
and source of water. Statistical analysis of a subset of 43 subjects matched for age and 
gender showed no difference among analyzed variables except for water intake (amount 
and source) see Appendix C. 
 
The age distribution for patient and control subjects is illustrated in Figure 3.1. 
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Figure 3.1: Age distribution for patients’ and control groups. 
 
3.2.Gender: 
 
The patients’ group (83 subjects) included 47 (56.6%) males and 36 (43.4%) females, 
while the control group (85 subjects) included 53 (62.4%) males and 32 (37.6%) females. 
 
Figure 3.2 shows the gender distribution between the two groups. There was no significant 
difference concerning gender distribution between the patients’ and control groups. 
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Figure 3.2: Gender distribution for patients and control groups. 
 
3.3.Body Mass Index (BMI): 
 
Body mass index (BMI) is the main indicator used to describe the weight problems in 
humans, overweight and obesity may reflect certain life style for individuals and may 
increase risk for certain factors to induce diseases and health problems. To calculate the 
BMI for subjects in this study, height and weight measures were collected for each 
contributor then BMI was calculated according to the following Rowland’s formula 
(Rowland et al., 1990): 
 
BMI (kg/m
2
) = weight (Kg)/ [Height (m) X Height (m)]. 
 
Values of BMI were grouped as recommended by the Centers for Disease Control and 
Prevention (CDC), Atlanta, Georgia, USA and the World Health Organization (WHO) as 
reproduced in Table 3.2 (WHO, 2004; CDC, 2013; WHO, 2013). The BMI for the 
patients’ and control group is shown in Table 3.3. 
 
 
 
57% 
43% 
Patients' group 
Male Female
62% 
38% 
Control group 
Male Female
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Table 3.2: Correlation of BMI values with weight status. (WHO, 2004; CDC, 2013; WHO, 
2013). 
BMI Values Weight Status 
≤ 18.4 Underweight 
18.5- 24.9 Normal 
25.0- 29.9 Overweight 
≥30 Obese 
 
Table 3.3: Patients and control subjects distributed according to their BMI groups. 
 
When comparing both groups, using Pearson’s Chi-Square test, a significant difference 
was observed (P= 0.033), specifically in the normal weight category. Indeed, although the 
mean BMI (27.2 kg/m
2) of the patients’ group was in the overweight category, while the 
mean BMI (24.7 kg/m
2
) of the control group was in the normal weight category; this 
reflects the fact that more than half (57.6%) of the control subjects are in the normal 
weight category,there was no significant difference obtained from the patients versus 
control groups. Figure 3.3 shows the different percentages of both groups distributed 
according to BMI.  
 
BMI Values Weight Status Patient No. (%) Control No. (%) P- value 
≤ 18.4 Underweight 3 (3.7%) 6(7.1%) >0.05 
18.0- 24.9 Normal 30 (36.6%) 49 (57.6%) 0.033 
25.0- 29.9 Overweight 28 (34.1%) 19 (22.4%) >0.05 
≥30 Obese 21 (25.6%) 11 (12.9%) >0.05 
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The relative reduction in the number of patients from normal BMI category in favor of 
overweight and obese categories reflects the increased risk of H. pylori infecting among 
overweight and obese subjects. 
 
Figure 3.3: Patients’ group versus control group percentages distributed according to BMI 
(Kg/m²) values. 
 
3.4.Smoking Habits: 
 
Every subject participated in this study was categorized as smoker or non-smoker. A 
smoker was defined as one who smoked any type of smoking materials for more than two 
months within the last two years. Among the patients’ group 26 (31%) subjects were 
smokers and 57 (69%) subjects were non-smokers. While in the control group25 (29.4%) 
subjects were smokers and 60 (70.6%) subjects were non-smokers (Figure 3.4). Using  
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Person’s Chi-square, no statistically significant difference was observed between the 
patients’ and control groups when compared for smoking habits.   
 
Figure 3.4: Distribution of patients’ and control groups by smoking habits.  
 
3.5.Drugs intake: 
 
Each subject in this study was evaluated for different drug intake other than the triple-
antibiotic therapy for H. pylori. Drugs that were considered in the questionnaire include 
those that were used by the study subjects for more than 2 months before the appearance of 
symptoms of H. pylori infection such as blood pressure controlling drugs, diabetes drugs, 
and others. From the patients’ group, 45 subjects (54.2%) were taking drugs and 38 
subjects (45.8%) were not. In the control group only 5 subjects (5.9%) were using drugs 
and 80 (94.1%) were not (Figure 3.5). 
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Figure 3.5: Distribution of patients and control groups based on their drug intake. 
 
Comparison of the patients’ and control groups for their drug intake using Person’s Chi-
Square analysis showed a statistically significant difference (P< 0.001) between the two 
groups.When patients on drugs were further sub-grouped based onto their BMI, ABO 
blood group, Lewis phenotype and secretor status, and analyzed statistically, no statistical 
differences among the subgroups were observed (data not shown).  
 
3.6.Exposure to pollution: 
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Polluted environment may expose subjects to different elements that predisposes or 
promotes infectious and non-infectious diseases by increasing exposure to microbial 
pathogens, immunosuppressing agents or toxic chemicals (i.e. pesticides). Analysis of the 
questionnaire data revealed that the patients’ group included 16 subjects (19.3%) who were 
exposed to environmental pollution, and 67subjects (80.7%) were not. On the other hand, 
16 subjects of the control group (18.8%) were exposed to environmental pollution and 69 
(81.2%) were not exposed (Figure 3.6). Comparison of the study groups for exposure to 
environmental pollution revealed no statistically significant difference between the two 
groups (P> 0.05). 
 
 
Figure 3.6: Exposure of patients’ and control groups (%) to environmental pollution. 
 
3.7.Water source and intake: 
 
Water may be one of the primary sources by which the bacterium is transmitted. Intake of 
H. pylori contaminated water may contribute to establishing the infection. Water intake 
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one liter a day, “Moderate” when the intake was between 1-2 liters a day, and 
“Adequate” when water intake exceeded two liters a day (Robinson et al., 1989). The 
intakes of other fluids like juice or tea were also included in calculating water intake. The 
distribution of study subjects according to water intake is shown in table 3.4. Analysis of 
data concerning water intake, showed that more than half of the patients (56.6%) fell in the 
moderate water intake category, while more than half (52.9%) of the control group fell in 
the adequate water intake category. A statistically significant difference was observed 
between the patients’ and control group concerning the water intakein the low category 
(P= 0.003) and adequate category (P=0.005).   
 
The source of drinking water (well or municipality tap water) was also recorded for the 
study subjects. From the patients’ group, 26 subjects (31.3%) were drinking well water and 
57 subjects (68.7%) were drinking municipality tap water. While from the control group 23 
subjects (27.1%) were drinking well water and 62 subjects (72.9%) were drinking 
municipality tap water. No statistically significant difference was observed between the 
two study groups concerning the source of drinking water (P> 0.05). 
 
Table 3.4: Water intake patients and control groups. 
Water intake 
quantity 
Patients’ group, 
No. (%) 
Control group, 
No. (%) 
P- value 
Low (<1L/day) 14 (16.9%) 2 (2.4%) 0.003 
Moderate (1-2L/day) 47 (56.6%) 38 (44.7%) >0.05 
Adequate (>2L/day) 22 (26.5%) 45 (52.9%) 0.005 
 
3.8.Consumption of spicy Food: 
 
Spicy and chilly foods were also evaluated to establish their role in mediating or 
predisposing to infection probably by irritating the intestinal tract. All study subjects were 
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asked to describe their intake of spicy and chilly food. For this purpose the study subjects 
were grouped into three categories: “none” for subjects who do not eat any spicy food or 
hot pepper at all; “moderate” for individuals who eat spicy food but cannot handle the hot 
pepper and “high” for individuals who consume spicy and hot pepper food. Table 3.5 
shows the distribution of patients’ and control groups by their consumption of spicy food.  
No statistically significant difference was observed between the two study groups 
concerning this factor (P> 0.05). 
 
Table 3.5: Consumption of spicy food by patients’ and control groups. 
Amount of spicy food 
consumption 
Patients’ Group 
No. (%) 
Control Group 
No. (%) 
P- value 
None 21 (25.3%) 13 (15.3%) >0.05 
Moderate 41 (49.4%) 46 (54.1%) >0.05 
High 21 (25.3%) 26 (30.6%) >0.05 
 
3.9.Correlation of ABO and Rh(D) phenotypes to H. pylori infection: 
 
Blood samples from each subject were tested to determine the ABO and Rh phenotypes of 
patients and control subjects. For this purpose, RBCs of the study subjects were tested with 
anti-A, anti-A1, anti-B and anti-D antibodies. 
 
Table 3.6 shows the ABO and Rh(D) phenotypes of the study subjects. The data showed 
that the prevalence of ABO blood groups among patients and controls was as follows: 
A>O>B>AB. The distribution of blood groups was similar among patients and controls. 
Indeed no statistically significant difference was observed among the patients’ group and 
control group concerning the distribution of ABO blood groups.  
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Table 3.7 shows the distribution of Rh (D) phenotype among patients’ and control groups. 
The results showed that the prevalence of Rh (D) positivity is similar among the two 
groups. No significant difference was observed among the patients’ and control group 
concerning the prevalence of Rh (D) phenotype. 
 
Table 3.6: Prevalence of ABO and Rh (D) phenotypes among patients’ and control groups. 
Blood Group Ag 
Patients’ group Control group 
No. % No. % 
O blood group 27 32.5 29 34.0 
ORh+ve 24 28.9 28 32.9 
O Rh-ve 3 3.6 1 1.1 
A blood group 34 41.0 34 40.0 
A1 Rh+ve 31 37.3 27 31.8 
A2 Rh+ve 1 1.2 3 3.5 
A1 Rh-ve 2 2.4 3 3.5 
A2 Rh-ve 0 0 1 1.2 
B blood group 12 14.5 14 16.5 
B Rh+ve 9 10.8 10 11.8 
B Rh-ve 3 3.6 4 4.7 
AB blood group 10 12.1 8 9.5 
A1B Rh+ve 7 8.4 6 7.1 
A2B Rh+ve 1 1.2 0 0 
A1B Rh-ve 2 2.4 1 1.2 
A2B Rh-ve 0 0 1 1.2 
Total 83 100 85 100 
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Table 3.7:Prevalence of Rh (D) phenotypes among patients’ and control groups. 
Rh (D) type 
Patients’ group Control group 
No. % No. % 
Positive 73 88 % 74 87 % 
Negative 10 12 % 11 13 % 
Total 83 100 85 100 
 
3.10. Lewis Antigens and Secretor status: 
 
3.10.1. Inheritance of Lewis Antigens: 
 
Phenotyping of Lewis antigens was determined using anti-Leᵃ and anti-Leᵇ. Subjects were 
tested and categorized in one of the following phenotypes: Le(a-,b-), Le(a-,b+), Le(a+,b-) 
and Le(a+,b+). 
 
The results showed that Leᵃ was positive in 16 patients (19.3%) and negative in 67 patients 
(80.7%), while it was positive in 30 (35.3%) control subjects and negative in 55 (64.7%) 
control subjects (Figure 3.7). This difference was statistically significant (P= 0.020) as 
determined by Person’s Chi-Squire test, with control group subjects showing Leᵃ on their 
RBCs than patients. Suggesting that Leᵃ to be more resistance marker. 
 
Leᵇ was positive in 43 patients (51.8%) and negative in 40 patients (48.2%), while it was 
positive in 36 (42.4%) of the control subjects and negative in 49 (57.5%) of the control 
subjects (Figure 3.7). This difference was not significant using the Person’s Chi-Squire 
(P= 0.220). 
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Regarding the inheritance of the Lewis phenotypes, individuals were categorized as 
follows: Le(a-,b-) in 24 (28.9%) patients and in 19 (22.4%) control subjects, Le(a-,b+) in 
43 (51.8%) patients and in 36 (42.4%) control subjects and Le(a+,b-) in 16 (19.2%) 
patients and in 30 (35.3%) control subjects. None of the study subjects showed the 
Le(a+,b+) phenotype (Figure 3.7). A statistically significant difference (P= 0.039) was 
observed between the patients’ group and control group regarding the Le(a+,b-) phenotype. 
 
Figure 3.7: Distribution of Lewis system phenotypes for patients’ and control groups. 
 
3.10.2. Inheritance of secretor gene: 
 
Inheritance of the Se gene was determined by testing saliva samples of study subjects for 
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patients and 47 (55.3%) of the control group, and the non-secretor status was found in 22 
(26.5%) of patients and in 38 (44.7%) of control subjects (Figure 3.8). A statistically 
significant difference (P= 0.039) was observed between the patients’ and control group 
concerning the non-secretor status, while no significant difference was observed between 
the study groups when compared for the secretor status (P> 0.05).  
 
 
Figure 3.8: Comparison of the secretor status between patients’ and control groups. 
 
Figure 3.9 shows a comparison between the patients’ and control groups for secretor status 
versus ABO/Rh(D) phenotypes.  
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Figure 3.9: Secretor status versus ABO/Rh(D) groups of patients’ and control groups. 
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3.11. H. pyloriIgG: 
 
The H. pylori specific IgG was determined by ELISA for the control group to assess 
previous asymptomatic exposure to H. pylori. Since the patients’ group was already 
evaluated for these bacteria it was necessary to determine whether the asymptomatic 
control group individuals had been previously exposed to H. pylori or healthy subjects who 
were not exposed to the bacterium at all. However, tolerant individuals will produce a 
negative result to that particular antigen as well and will show negative IgG results.  
 
Serum samples were tested twice (two independent assays) for the H. pyloriIgG. The 
results showed that 83 (97.6%) of the control subjects were positive and only 2 subjects 
(2.4%) were negative for H. pylori IgG. As a result, the control group was considered to be 
asymptomatic, except for the two true negative subjects, who may be true negative or 
immune-tolerant. 
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Chapter Four: 
 
 
4. Discussion: 
 
Helicobacter pylori infection may lead to ulceration of the gastric mucosa and duodenum; 
it is strongly associated with the development of epithelial and lymphoid malignancies of 
the stomach. The prevalence of H. pylori infection varies geographically. In addition 
several factors may contribute to its pathogenesis (Li et al., 2003; Martins et al., 2006; 
Torres et al., 2008;Barghouthi, 2009; Muhsenet al., 2012; Tonkic et al., 2012; Yamamoto 
et al., 2012). 
 
Treatment of H. pylori aims to eradicate 90% of the bacterium, so patients are given a 
combination of two antibiotics plus a proton pump inhibitor and this is considered as a first 
line treatment. However; frequent use of antibiotics during childhood is associated with a 
decline in eradication rates of the bacterium(Ertem, 2012) reports of increasing bacterial 
resistance have been reported (Barghouthi, 2009). 
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The study samples were collected between January 2012 and January 2013. The study was 
performed at Al-Quds University Research Laboratory and Augusta Victoria Hospital 
Laboratory. 
 
After detecting the IgG of H. pylori in the control group, the results revealed an 
astonishing high rate (98%) of asymptomatic infection with H. pylori among the control 
group. This was an indicator to consider the control group to consist of asymptomatic 
subjects.While the patients’ group showed the clinical symptoms of H. pylori infection that 
was confirmed by laboratory findings of the bacteria in stomach biopsies or bacterial 
antigens in stool or H. pylori specific IgA in serum.Comparison between the two groups 
was performed using different predictive factors.Both host and bacterial factors may 
contribute to differences in H. pylori pathogenicity. Half of the world population is 
reported to be infected with this bacterium (Barghouthi, 2009). Although the prevalence of 
H. pylori infection is declining in some developed countries, the prevalence of infection in 
Asia and other developing countries is still high. Human host is considered to be the 
principle reservoir of the bacterium and transmission is believed to occur via person to 
person. Also several studies observed that children acquire H. pylorifrequently from their 
mothers. On the other hand, unclean water has been implicated in the transmission ofH. 
pylori infection (Wu et al., 2003; Ertem,2012; Valliani et al., 2013). 
 
The subjects of both study groups were from different Palestinian cities in order to have 
contributors with different exposing factors, such as pollution, water sources, culture 
habits, and different genetic elements.  
 
4.1.Serological Detection of anti- H. pyloriIgG: 
 
Testing for H. pylorispecific IgGindicated bacterial exposure, asymptomatic subjects 
showedthat about 98% of the control group were positive for this antibody. Therefore, this 
 48 
 
test cannot be employed as a diagnostic tool for this infection, this can be useful if only 
accompanied with clinical symptoms and/or verified by other means. The test is useful in 
showing equal exposure and differentiating between symptomatic and asymptomatic 
subjects. The mean IgG concentration for the asymptomatic group was about 
109.9NTU/mL (SD= 60.1). Comparison of the IgG titer of symptomatic patients 
(determined for few random samples) with the mean titer of the control group 
(asymptomatic subjects)revealed no significant difference 
 
Although serologic testing for H. pylori by detectingIgG antibodies have been proven to be 
useful in supporting the clinical diagnosis of infection with this bacterium. Serum 
immunoglobulin detection are considered good indicators to evaluate and diagnose the 
infection and treatment of H. pylori (Jaskowski et al., 1997; Li et al., 2003),  this study 
showed that physicians must not relay on the IgG blood testing to evaluate patients for H. 
pylori infections because exposure to bacteria does not mean to suffer from symptoms, so 
there should be other ways to evaluate patients with symptoms in order to be confirmed of 
having problems due to H. pyloriinfection or there are other reasons for these troubles.  
 
Prevalence of H. pylori asymptomatic infections in the Middle East was determined to be 
increasing with age (Novis et al., 1998; Muhsen et al., 2012; Tonkic et al., 2012). A recent 
study conducted on Jewish and Arab patients, showed that H. pylori infection was low 
among children, reached 39% in the second and third decades and further increased to 79% 
in those over 60 years old (Muhsen et al., 2012). Infection prevalence rates are higher in 
patients of Mediterranean and Asian origin (around 89%) compared to Western European/ 
North American origins (57%). The latter findings reflects the important role of socio-
economic effect on the prevalence of H. pylori infection (Novis et al., 1998; Hussein, 
2010), suggesting that socioeconomics variables including hygienic standards play major 
roles in the transmission of the pathogen.  
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4.2.Age: 
 
The mean age for symptomatic patients was higher than that of the control group 
(asymptomatic subjects) due to the low response rate among older individuals to 
participate in the study (in the control group). Therefore, the study groups were not 
matched concerning the age parameter. All the study subjects are adults and were older 
than 15 years, thus it is unlikely that the age may pose a risk for contacting the infection. A 
recent study from Iran, a developing country, investigated 458 children and found that the 
rate of H. pylori positivity was increasing with age and rose from 43.6% by 4 months of 
age to 90% by 15 years of age (Soltani et al., 2013). In our study, testing of the control 
group revealed that about 98% of the subjects were positive for H. pylori specific IgG in 
serum, which means that the majority of the control subjects were previously exposed to 
H. pylori but remained asymptomatic. The use of this asymptomatic control group for 
comparison with symptomatic patients’ group provides an advantage that both groups were 
exposed to the bacterium but certain host factors have probably influenced the course of 
infection, to remain asymptomatic or to develop into a symptomatic infection. However, in 
comparison with other studies that showed a lower rate of H. pylori infection 45-60% 
regarding the age of individual in Muhsenet al., 2012 the age range was 0- 77 years. . (Li et 
al., 2003; Martins et al.,  2006;Torres et al., 2008;Ertem, 2012; Muhsenet al., 2012; Tonkic 
et al., 2012). 
 
This difference in age between the whole study groups has no effect on all variable 
investigated in this study except for the amount of water intake and source of water, as 
shown in Appendix C  by statistical analysis of a subset of 43 subjects matched for age and 
gender. 
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4.3.Gender: 
 
It was essential to compare both groups with similar gender distribution in order to 
determine whether there was a significant correlation between the symptoms of infection 
and gender of individuals. In this study no significant difference was observed between 
both genders concerning H. pylori infection. This result is in accordance with previous 
studies (Fiedoreket al., 1991; Graham et al., 1991; Turkolmezet al., 2007; Petrovic et al., 
2011). Yet, our result disagrees with other studies from Turkey and Iraq (Kanbay et al., 
2005; Jaff et al., 2011) which showed that male gender as a protective factor for infection 
while females were more susceptible to H. pylori complications. 
 
4.4.Source of drinking water: 
 
Water sources are limited in Palestine and they were categorized into tap water and rain 
water collected by water wells. There was no significant difference (P-value>0.05) 
between the source of drinking water and symptomatic infection with H. pylori. Although 
the role of drinking water in transmission of H. pylori is not confirmed, recent studies 
reported that, water contamination may play a role in transmission of the bacterium 
(Ertem; 2012). However, further studies that include young children and a controlled and 
characterized source of drinking water is needed to determine the role of water in 
transmission of H. pylori and whether it contributes to the high seropositive asymptomatic 
individuals among Palestinians. 
 
4.5.Water intake: 
 
High water intake habits are necessary to maintain body hydration levels and cellular 
integrity. Water has several advantages and benefits for body tissues. After comparing the 
two study groups, for amounts of water intake, it was observed that the patients’ group 
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were drinking less water (P<0.05) than control group, indicating that water intake may 
have a protective effect against symptomatic infection. A possible explanation include that 
adequate water intake increases the hydration of mucous membranes and enhances the 
effect of innate immunity in the mucous or secretions surrounding the mucous membranes 
of the digestive tract. Further investigation of this issue at the cellular level may provide 
more accurate explanations for this point.   
 
4.6.Pollution and Smoking Habits: 
 
The environmental contamination may play a primary role in bacterial transmission 
through contaminating food and water sources, individuals who carry H. pylori may 
transmit it to others by contaminating the environment leading to infecting others. No 
significant difference between the two study groups concerning environmental pollution 
was observed in this study.  Palestine is not considered as an industrialized country so the 
chemical remnants are probably limited and not polluted. The level of exposure to 
environmental contamination is difficult to measure. Thus it is better to investigate the 
effect of this factor on H. pylori infection using a larger sample and to limit the study to 
specific regions with clear differences in environmental contamination or to measure 
certain indicators of pollution.  
 
Concerning the effect of smoking on H. pylori infection, no statistically significant 
difference was observed between the study groups concerning this factor, this finding is 
consistent with the finding by Valliani et al. (2013) from Pakistan. The latter finding was 
in contrast with a study in Turkey that found smoking as a protective factor against 
infection with H. pylori (Kanbay et al., 2005). 
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4.7.Consumption of Spicy food: 
 
Since food is considered one of the primary factors affecting and influencing 
gastrointestinal tract diseases (Singh et al., 2006; Yassibas et al., 2012); spicy and chilly 
food was evaluated for its contribution for the development of symptomatic infection with 
H. pylori. In our study there was no significant correlation between consumption of spicy 
food and H. pylori infection. 
 
The general public usually relates gastritis as a temporary reaction to spicy/ chilly- foods. 
Indeed some reports indicated that spicy foodinfluences gastrointestinal diseases (Singh et 
al., 2006; Yassibas et al., 2012). In this study, there was no correlation between spicy food 
and symptomatic infection with H. pylori. 
 
4.8.Drug intake: 
 
Drugs are composed of different chemicals, many of which when taken in excess doses, in 
combination or for a period longer than indicated for such drugs, may cause adverse effects 
on the stomach tissues (Kuhn et al., 2010). In this study, there was a significant difference 
between the study groups, concerning the intake of drugs (P <0.001).  
 
It seems that individuals who are using drugs for a long time may be at risk of developing 
symptomatic H. pylori infection. It also may indicate that individuals with underlying 
infections or disorders may be predisposed to developing symptomatic infections of H. 
pylori. 
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4.9.Body Mass Index (BMI): 
 
Body mass index (BMI) may reflect the food intake habits and physical activities of 
participating subjects. It was found that the patients’ group showed significantly higher 
BMI values than the control group. This evidence supports the view that feeding habits 
(quantities and frequencies of feeding) may impact the function of the stomach and 
influence the interaction of the stomach cells with invading pathogens. It may also 
contribute to intake of higher infectious doses of the bacterium H. pylori. Whether obesity 
is directly or indirectly responsible for this association still awaits further investigation. 
 
 A statistically significant difference (P= 0.033) was observed between the patients’ and 
control groups when compared for the BMI. Indeed the mean BMI for the control group 
being in the normal category and the mean BMI for the patients group being in the 
overweight category. This finding suggests that overweight may be predisposing for H. 
pylori infection. 
 
4.10. ABO and Rh: 
 
Many studies found a strong relationship between ABO and Rh antigens and H. pylori 
infection, this correlation is due to the different glycosylation patterns of RBC antigens. 
Several pathogens have been demonstrated to use certain RBC antigens as receptors that 
facilitate adherence of the pathogen. Analysis of ABO blood groups and Rh (D) antigen 
distribution among the study subjects, showed no significant difference between the study 
groups. The primary results showed that the blood group A1 Rh+ve was slightly higher in 
the patients’ group and the blood group O Rh+ve was slightly higher in the control group, 
but this difference was not statistically significant. The distribution of ABO blood groups 
was close to that reported among the Palestinian population (Al-Kawasmi, 2011). 
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No significant difference was observed between the study groups when compared for the 
ABO and Rh antigen, which is consistent with previous reports (Jaff et al., 2011; Petrovic 
et al., 2011).While other studies have found a significant correlation between blood groups 
and H. pylori infection. In certain patients a significant association was found between 
infection and O blood grouping with Leᵇ and secretor inheritance (Kanbay et al., 2005; 
Martius et al., 2006; Bayan et al., 2009;Anstee, 2010; Yamamoto et al., 2012; Valliani et 
al., 2013). 
 
The variations between different studies and correlations found within certain blood groups 
may be explained by the difference in epidemiological distribution and prevalence of 
particular blood groups. Therefore, it is noticed that blood group antigen effect is not that 
significant and the increase in certain antigen is due to the degree of dominance of ABO 
antigens in the population. In the present study, the finding that 98% of the control group 
were asymptomatic and previously have been exposed to H. pylori, suggests that, at least 
among our study subjects, the ABO blood group is not associated with H. pylori infection.  
 
4.11. Lewis Antigens and Secretor Status: 
 
Lewis antigens are described to resemble some H. pylori antigens that are carried by this 
bacterium and helps in its adhesion and interaction with host cells. The Lewis antigens (Leᵃ 
and Leᵇ) are produced through interaction of Lewis (FUT3) gene and Secretor (FUT2) 
gene. (Magdalena et al., 1998; Hynes et al., 2000; Monteiro et al., 2000; Mcguckin et al., 
2007; Torres et al., 2008; Anstee, 2010; Yamamoto et al., 2012). In this study, the Leᵃ 
antigen which correlates with the non-secretor phenotype was observed in a significantly 
(P-value= 0.020) less frequency in the patients’ group compared to the control group. 
Previous studies have shown Leᵇ antigen acts as a receptor for H. pylori and correlates with 
the secretor phenotype (Valliani et al., 2013).There was trend toward slightly a higher 
frequency in patients compared to the control group. This finding was further supported by 
the frequency of the secretor phenotype among the study groups discussed in the next 
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paragraph. These findings are consistent with previous reports that reported a role for 
Lewis antigens in the binding of H. pylori to the stomach mucosal cells (Hynes, 2000; 
Magdalena, 1998; Monteiro, 2000; Anstee, 2010; Yamamoto et al., 2012; Valliani et al., 
2013). 
 
An important finding of this study is the different distribution of the secretor phenotype 
among the study groups. Secretor phenotype showed similar expression in the patients’ 
group compared to the control group (P>0.05) and the non-secretor phenotype was found 
in a significantly lowerfrequency (P-value= 0.014) in the patients’ group compared to the 
control group.  Inheritance of Le (a+,b-) phenotype is associated with the non-secretor 
phenotype while the inheritance of Le(a-b+) is associated with the secretor phenotype. 
Additionally, the number of Leᵇ antigens per red cell is higher than Leᵃ antigens 
(Harmening, 2005). Taken together, individuals with Le(a-b+) phenotype/ secretor 
phenotype has more Lewis antigens per cell compared to individuals with the Le(a+b-) 
phenotype/non-secretor phenotype. Since the H. pylori has been reported to use the Lewis 
antigens for attachment or adherence to the stomach mucosal cells, it can be deduced that 
individuals with the Le(a-b+) phenotype/secretor phenotype may facilitate infection with 
this bacterium. This finding is consistent with the findings reported by earlier reports 
which suggested that H. pylori needs high Leᵇ antigen concentration on the host cells to 
facilitate its attachment and colonization on host cells (Magdalena et al., 1998; Lee et al., 
2006; Harvey et al., 2010; Yamamoto et al., 2012). Alternatively, the non-secretors express 
only Leᵃ which is usually found in a lower concentration compared to Leᵇ, which in turn 
may reduce the potential attachment sites for H. pylori. 
 
4.12. Conclusion: 
 
This study was a case-control study. The patients’ group has experienced symptomatic H. 
pylori infection. In the control group or asymptomatic group, the majority of the subjects 
(98%) was exposed to H. pylori pathogen but did not show any symptoms of infection. To 
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the best of our knowledge, this study is the first study of its kind in Palestine. Comparison 
of the study groups, showed significant association between H. pylori infection and BMI, 
drug intake, amount of water intake, Lewis phenotype and secretor property. While 
comparison of the study groups, showed no statistically significant association between H. 
pylori infection and gender, drinking water source, spicy and chilly food intake, smoking, 
exposure to environmental pollution and ABO/Rh group.  
 
4.13. Future Work: 
 
Future testing for the H. pylori behavior and infection mediating factors is still 
recommended especially to study the H. pylori exposure status among age groups, and to 
use certain genetic studies to determine the blood antigens affecting the infection and 
bacterial antigens chemical contents responsible for the adhesion and attachments to be 
blocked by certain reactions. On the other hand the analysis of drugs and their chemical 
components mediating the infection and improving its pathological characteristics. In 
addition, further investigations are needed to examine the effect of BMI and water intake 
on H. pyloriinfection. 
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 جامعة القدس/ كلية الدراسات العليا/ ماجستير علوم طبية مخبرية                                           استمارة بحث علمي
 اسم الباحث: علا كرمي
 
 :/السيدالسيدة 
دساست حٛي "  بإػذاد-بإششاف اٌذوخٛس ِحّٛد سشٚس ٚ اٌذوخٛس سّ١ش اٌبشغٛرٟجبِؼت اٌمذس – علا كرمًحمَٛ اٌببحزت 
 . "فٍسط١ٓ -فٟ اٌؼفت اٌغشب١ت ٚ فظ١ٍت اٌذَ  بىخ١ش٠ب اٌٍٙ١ىٛببوخش ب١ٍٛسٞ
إعطاء عٌنات دم و لعاب ٚ اٌّٛافمت ػٍٝ  ت الاسخب١بْ اٌّشفكٚ ٌزٌه ٔشجٛ ِٓ حؼشحه اٌخؼبْٚ ِغ اٌببحزت بخؼبئ
 لاستخدامها فً هذا البحث.
 
سٛف ٠خُ اٌخؼبًِ ِغ اٌؼ١ٕبث ٚ ٔخبئج اٌبحذ بسش٠ت ٚ خظٛط١ت وبٍِت، أِب ٔخبئج اٌبحذ فسٛف حسخؼًّ لأغشاع ٚ 
 .ذ اٌؼٍّٟ فمؾاٌبح
 ٚ س١خُ إػلاِىُ بٕخبئج اٌبحذ ػٕذ الأخٙبء ِٓ اٌذساست.
 
 ٘زا اٌبحذ،،،،، لإٔجبحّؼٍٝ حؼبٚٔىشىشٞ ٚ اِخٕبٔ١ ُألذَ ٌى
 
 --------------------------------------------------------------------------------------------------------------------
 معلومات عامة:
 
 :رقم المشارك .1
 العمر: .2
 أنثى -ذكر                ب -الجنس:  أ .3
 الطول: .4
 الوزن: .5
 ):xedni ssam ydoB(لحساب 
 ما هً فصٌلة دمك: .6
 لا -نعم                        ب -هل تدخن: أ .7
 إذا كنت تدخن فاذكر العمر الذي بدأت به التدخٌن:
 كم الفترة التً دخنت بها من دون انقطاع:
 منطقة السكن: .8
 المدٌنة:                        القرٌة:
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لا              -نعم           ب -............الخ): أ ، تعمل فً مصنعفٌها تلوث (مكب نفاٌاتمن منطقة  اقرٌب تقطنهل  .9
 حدد:
 لا                   حدد: -نعم                 ب -هل تشرب من مٌاه أبار الجمع (الأمطار): أ .01
أتناولها فً كثٌر من  -ج        لتر)    2-1متوسط ( -قلٌلا (أقل من لتر)          ب -كٌف تصف شربك للماء: أ .11
 )لتران من الماءالأحٌان (
أتناولها فً كثٌر من  -قلٌلا           ج -لا أتناولها نهائٌا          ب -كٌف تصف تناولك للطعام الحار و الفلفل: أ .21
 الأحٌان
 
 ):15إذا لم تكن مصابا بأعراض القرحة في حياتك الرجاء الذهاب للسؤال رقم( 
 الطرٌقة التً كانت متبعة فً تشخٌص مرض القرحة:ما هً  .31
غٌر ذلك، حدد:  -لا أعرف    هـ -فحص تنفس        د -خزعة من المعدة      ج -فحص دم      ب -أ 
 ____________
--------------------------------أذكر أمور أخرى تزٌد أعراض المرض لدٌك و غٌر موجودة فً الأسئلة السابقة:  .41
-----------------------------------------------------------------------------------------------------------
 ----------------
   نعم -ب           لا -:  أهل هناك أشخاص في عائلتك مصابين بأمراض في الجهاز الهضمي أو القرحة .51
 
   حدد صلة القرابة:     حدد نوع المرض: 
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 جامعة القدس/ كلية الدراسات العليا/ ماجستير علوم طبية مخبرية           اسم الباحث: علا كرمي
 
 
أنا:                                                 الموقع أدناه، أوافق على المشاركة بالبحث العلمً الذي تقوم به الباحثة 
غوثً عن بكتٌرٌا الهلٌكوباكتر سمٌر البر جامعة القدس بإشراف الدكتور محمود سرور و الدكتور -علا كرمً
و علاقتها بفصٌلة الدم، و أوافق على استخدام المعلومات التً ٌطلبها الباحث فً أغراض البحث العلمً، و  باٌلوري
 أوافق على إعطاء عٌنات دم و عٌنات لعاب لاستخدامها فً هذا البحث.
 توقٌع:ال
 التارٌخ:
 
 توقٌع الباحث:
 
 
 
 
 
 
 
 لاستعمال الباحثة فقط.
 سلُ الاسخب١بْ :.................
..............ساجغ اٌّؼٍِٛبث:
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Appendix C: Comparison of an age-matched subset of the patients’ and control 
groups  
 
Analysis of the patients’ and control groups with regard to age, revealed a statistical 
significant difference (P=0.000). In order to determine if this difference has affected the 
findings of this study with regard to other variables studied in this study, we have matched 
43 patients and 43 control subjects with regard to age and gender. Statistical analysis of 
this matched subset revealed that the factors that have significant difference were the same 
as the whole group, which were: high body mass index, increased drugs intake, no 
inheritance to Leᵃ antigen and inheritance of Se gene (i.e., having the secretor phenotype). 
While factors that did not show any significant difference between the patients’ and control 
groups were also the same as the whole group, namely: spicy and chilly food intake, 
smoking, exposure to environmental pollution and ABO/Rh grouping. 
 
However, the statistical analysis of the age-matched subset was contradictory to the 
findings observed with the whole groups with regard to the amount of water intake and the 
source of water. Analysis of the patients’ and control groups (whole groups) revealed a 
significant difference between groups when compared with regard to the amount of water 
intake, while no significant difference was observed between groups when compared with 
regard to the source of water. In contrast, analysis of the age-matched subset, did not reveal 
a significant difference between groups when compared with regard to amount of water 
intake, and revealed a significant difference between groups when compared with regard to 
the source of water.  Therefore, we believe that further investigations are needed using a 
larger sample to study the association between the amount of water intake and source of 
water and H. pylori infection.  
 
Statistical analysis was performed using the same methods used to analyze the whole study 
groups namely the Pearson’s Chi- square test.  
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و نىع فصيلة الدم و قدرة الشخص الإفرازية  بكتيريا الهليكىباكتر بيلىريالعلاقة بين 
 في فلسطين
 
 إػذاد: ػلا ؽلاي ػبذ الله وشِٟ.
 
 .إششاف: د. ِحّٛد سشٚس، ٚ د. سّ١ش اٌبشغٛرٟ
 
 
 الملخص:
 
ِغ ػذة أٔٛاع ِٓ  ٚجذ أْ ٌٗ ػلالتاٌغلاف اٌخٍٛٞ ٌىش٠بث اٌذَ اٌحّشاء ٚ ِب ٠شحبؾ بٗ ِٓ أٔخ١ج١ٕبث 
ّلاحظت أْ بىخ١ش٠ب اٌّؼذة اٌذل١مت اٌّّشػت. ٚ ب ٌٗ حسبس١ت ٌؼذة أٔٛاع ِٓ اٌىبئٕبث أْ الأِشاع، وّب
ٚ الاٌخٙبببث اٌّشافمت ٌٙب ِشحبطت ِغ الأٔخج١ٕبث اٌّخخٍفت اٌخٟ ححٍّٙب خلا٠ب  اٌحٍضٚٔ١ت اٌّسببت ٌٍمشحت 
اٌخٟ حض٠ذ خطٛسة إحذاد أػشاع ِشػ١ت حذ٠ذ اٌؼٛاًِ سبث ِخؼذدة ػٍٝ حدسا وبْ ٕ٘بناٌذَ اٌحّشاء 
 اٌجشرِٛت.ٌذٜ الأشخبص اٌز٠ٓ ٠ظببْٛ بٙزٖ 
 
ٙزٖ اٌذساست ٘ٛ اٌبحذ فٟ اٌؼلالت ب١ٓ الإطببت ببىخ١ش٠ب اٌمشحت ِغ ٔجبح اٌبىخ١ش٠ب فٟ اٌٙذف الأسبسٟ ٌ
ٌّشع ِٓ جٙت ٚ ٔٛع فظ١ٍت اٌذَ ٚ ٔٛع الأٔخج١ٕبث اٌخٟ ححٍّٙب ِٓ ِؼبػفبث اإحذاد أػشاع ٚ 
لببٍ١ت ، ٚ ِٓ ٔبح١ت 2Aأٚ  1Aسٛاء وبْ  Aٚ ٔٛع الأٔخج١ٓ اٌخبص بـ  siweLٚ  )D( hR /OBA
 اٌشخض لإفشاص الأٔخج١ٕبث فٟ اٌّشػٝ اٌفٍسط١ٕ١١ٓ. 
 
اٌز٠ٓ ظٙشث ػٍ١ُٙ أػشاع  ِش٠غ) 83اشخٍّج اٌذساست ػٍٝ ِجّٛػخ١ٓ: ِجّٛػت اٌّشػٝ (
أٞ ِٓ أػشاع  ػٍ١ُٙ اٌز٠ٓ ٌُ حظٙش شخض) 83اٌّجّٛػت اٌؼببطت (ٚ طببت بجشرِٛت اٌّؼذة الإ
 اٌجٕس ٚ وزبفت اٌجسُ ٚ ػبداث اٌخذخ١ٓ ٌٚفشق ب١ّٕٙب ِٓ ٔبح١ت ا دساستطببت ببٌجشرِٛت، ٚلذ حُ الإ
ِمذاس اٌخؼشع ِظذس٘ب ٚٚ  وّ١ت اٌّبءٚ  ػُٙ ٌٍٍّٛربث اٌب١ئ١تشحؼحؼبؽٟ اٌشخض ٌلأدٚ٠ت اٌّخخٍفت ٚ
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لببٍ١ت ٌحّشاء ٚأٔٛاع الأٔخج١ٕبث اٌّخخٍفت اٌخٟ ححٍّٙب وش٠بث اٌذَ اٚ ببلإػبفت ٌٕٛع اٌذَ  ٌٍطؼبَ اٌحبس
ب١ٓ أػشاع ئ١ب ٌّلاحظت ٚجٛد اسحببؽ ب١ٕٙب ٚ٘زٖ اٌؼٛاًِ حّج دساسخٙب إحظب فشاص٠ت.اٌشخض الإ
 الإطببت ببىخ١ش٠ب اٌمشحت.
 
%) لذ حؼشػٛا ٌجشرِٛت اٌّؼذة ح١ذ حُ وشف 38أظٙشث إٌخبئج أْ ٔسبت ػبٌ١ت ِٓ اٌؼ١ٕت اٌؼببطت (
اٌخؼشع لأػشاع الاٌخٙبة جسبَ اٌّؼبدة ٌٍجشرِٛت فٟ ِظً اٌذَ، ِغ اٌؼٍُ أُٔٙ ٌُ ٠سبك ٌُٙ الأ
طت ٌٛحع ٚجٛد ػلالت راث دلاٌت بببىخ١ش٠ب اٌمشحت. ٚببٌّمبسٔت ب١ٓ ِجّٛػت اٌّشػٝ ٚاٌّجّٛػت اٌؼب
وّ١ت اٌّبء اٌخٟ ٚحٕبٚي الأدٚ٠ت، : وزبفت اٌجسُ،ٚػٛاًِ حشًّٚػذة طببت ببٌجشرِٛت إحظبئ١ت ب١ٓ الإ
ػٍٝ وش٠بث دِٗ اٌحّشاء ٚ خلا٠ب جسّٗ، ٚ لببٍ١خٗ  siweLحٍّٗ ٌٕٛع الأٔخج١ٓ ٚ٠خٕبٌٚٙب اٌشخض، 
راث دلاٌت إحظبئ١ت ب١ٓ  وّب ظٙش أرٕبء اٌّمبسٔت أٔٗ لا ٠ٛجذ ػلالت الإفشاص٠ت ٌلأٔخ١ج١ٕبث اٌّخخٍفت.
حٕبٚي اٌطؼبَ اٌحبس اٌخبٌ١ت: اٌجٕس، ِٚظذس اٌّبء اٌزٞ ٠خُ حٕبٌٚٗ، ٚ طببت ببٌجشرِٛت ٚاٌؼٛاًِالإ
ِب ٠حٍّٗ ِٓ أٔخ١ج١ٕبث شع ٌٍٍّٛربث اٌب١ئ١ت اٌّخخٍفت، ٚٔٛع دَ اٌشخض ٚؼاٌخٚاٌخذخ١ٓ، ٚاٌحبد، ٚ
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ٚوٕخ١جت ٌٙزا اٌبحذ ظٙش ٕ٘بن ٔسبت ػبٌ١ت ِٓ اٌحبٍِ١ٓ ٌجشرِٛت بىخ١ش٠ب اٌمشحت فٟ اٌّجخّغ 
 س أػشاع اٌّشع ػٕذ الاطببت بجشرِٛت اٌّؼذة ٠شحبؾ بؼٛاًِ ٠حٍّٙب ٛظٙش أ٠ؼب أْ ظٙاٌفٍسط١ٕٟ، 
 الإٔسبْ ٚأخشٜ ِٓ اٌب١ئت اٌّح١طت.
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